| Trial ID: | L2784 |
| Source ID: | NCT01028404
|
| Associated Drug: |
Nn1952
|
| Title: |
A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Healthy
|
| Interventions: |
DRUG: NN1952|DRUG: insulin aspart|DRUG: placebo|DRUG: NN1952|DRUG: insulin aspart|DRUG: placebo
|
| Outcome Measures: |
Primary: Number and severity of adverse events for trial part 1, from visit 1 to visit 3|Number and severity of adverse events for trial part 2, from visit 1 to visit 6 | Secondary: Area under the serum insulin concentration-time curve after a single dose, after 12 hours|Area under the glucose infusion rate-time curve after a single dose, after 12 hours
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
84
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-11
|
| Completion Date: |
2010-06
|
| Results First Posted: |
|
| Last Update Posted: |
2017-07-25
|
| Locations: |
Novo Nordisk Investigational Site, Neuss, 41460, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01028404
|
